Helix BioPharma (TSE:HBP) Shares Pass Above 50-Day Moving Average – Here’s What Happened

Helix BioPharma Corp. (TSE:HBP) shares crossed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of C$2.08 and traded as high as C$2.10. Helix BioPharma shares last traded at C$2.05, with a volume of 607 shares changing hands.

Helix BioPharma Stock Up 1.5%

The firm’s 50 day moving average price is C$2.08 and its two-hundred day moving average price is C$2.10. The firm has a market capitalization of C$158.87 million, a PE ratio of -29.71 and a beta of 0.18. The company has a quick ratio of 1.04, a current ratio of 0.23 and a debt-to-equity ratio of 2.19.

About Helix BioPharma

Helix BioPharma is an oncology company that innovates from strength to bring near-term solutions for today’s hardest-to-treat cancers. The Company’s pipeline is led by Tumor Defense Breaker¿ L-DOS47, a clinical-stage antibody-enzyme conjugate designed to prime CEACAM6-expressing tumors for increased sensitivity to therapy and augment the effectiveness of today’s front-running anti-cancer treatments. L-DOS47 has completed Phase Ib studies in non-small cell lung cancer (NSCLC) and shares its CEACAM6-targeting foundation with Helix’s next-generation bi-specific antibody-drug conjugates (ADCs), currently in discovery.